Jordan Park

Jordan Park

Healthcare & Biotech Analyst

Healthcare and biotech analyst focused on pharma pipelines, medtech adoption curves, and reimbursement dynamics. Former clinical research coordinator and later equity research analyst. Writes thesis-driven pieces that connect clinical catalysts, competitive landscapes, and valuation scenarios.

Articles 769

Jan 7, 2026 Finance

Baker Hughes Approaches Q4 Earnings with Focus on Industrial Tech and Oilfield Services Performance

Investor scrutiny intensifies ahead of full-year report as segment resilience and contract wins set expectations

Baker Hughes Company is preparing to release its fourth-quarter and full-year 2024 earnings on January 25, 2025, with considerable investor interest c...

GameStop CEO Ryan Cohen Faces Ambitious Incentive Plan Worth Up to $35 Billion
Jan 7, 2026 Business News

GameStop CEO Ryan Cohen Faces Ambitious Incentive Plan Worth Up to $35 Billion

Potential Massive Reward for Cohen Hinges on Dramatic Market Value and Profit Growth

Ryan Cohen, Chief Executive Officer of GameStop, may stand to gain a substantial financial award valued at $35 billion, contingent on the company achi...

Big Ten Titans Indiana and Oregon Set to Clash in Peach Bowl Semifinal
Jan 7, 2026 News & Politics

Big Ten Titans Indiana and Oregon Set to Clash in Peach Bowl Semifinal

A Showcase of Power and Strategy in the College Football Playoff

The College Football Playoff semifinal at the Peach Bowl features unbeaten Indiana and formidable Oregon, underscoring the Big Ten's rising dominance ...

Jan 7, 2026 Finance

Mobileye Expands Horizons with Robotaxis and Robotics at CES 2026

Automaker Partnerships and Strategic Acquisition Signal Growth Beyond Driver Assistance Systems

At CES 2026, Mobileye Global Inc. introduced ambitious growth strategies by not only highlighting its advancements in autonomous driving and robotaxi ...

Jan 7, 2026 Finance

FDA Grants Priority Review to Vera Therapeutics’ At-Home Therapy for Kidney Disease

Atacicept targets IgA nephropathy with potential for weekly self-injection treatment

Vera Therapeutics has secured Priority Review status from the FDA for its biologics license application of atacicept, an investigational weekly subcut...

Jan 7, 2026 Finance

D-Wave Quantum Advances with $550 Million Acquisition of Quantum Circuits Inc.

Merger Aims to Integrate Diverse Quantum Computing Technologies and Accelerate Development of Fault-Tolerant Systems

D-Wave Quantum Inc. announced a decisive acquisition of Quantum Circuits Inc. in a $550 million transaction, combining two prominent quantum computing...

Inside 'The Pitt' Season 2: Deeper Character Journeys Amid Medical Drama
Jan 7, 2026 News & Politics

Inside 'The Pitt' Season 2: Deeper Character Journeys Amid Medical Drama

Noah Wyle Returns as Dr. Robby in a Season Focused on Trust, New Challenges, and Contemporary Healthcare Issues

The second season of the acclaimed medical drama 'The Pitt' resumes with Noah Wyle reprising his role as Dr. Michael Robinavitch (Robby), embarking on...

Jan 7, 2026 Trade Ideas

Visa: Easy Consumer Exposure With Defensive Cash Flow and a Tactical Long Setup

Own the consumer via the payments network — buy on weakness, stop tight, targets for a 10-20% move

Visa is the global payments backbone: nearly $17 trillion processed in fiscal 2025, high operating margins, and recurring cash flow. Use a tactical lo...

Trade Idea Long
Jan 7, 2026 Trade Ideas

Zscaler: Buy the Re-Rate — Growth Is Real; KPI Noise Creates a Trade Window

Strong cash conversion, high gross margins and accelerating revenue create a tactical long setup after recent weakness

Zscaler reported 08/01/2025-10/31/2025 (Q1 FY2026) revenue of $788.1M (+~25.5% YoY vs prior-year quarter), 76.5% gross margin and positive operating c...

Trade Idea Long
Jan 7, 2026 Finance

Concentrix Poised for Dip in Q4 Earnings As Analysts Adjust Forecasts Ahead of Earnings Report

Mixed analyst outlooks surround Concentrix as it prepares to announce fourth-quarter results reflecting earnings decline but revenue growth

Concentrix Corporation is set to announce its fourth-quarter earnings with analysts anticipating a decline in earnings per share compared to the previ...